Literature DB >> 19129693

Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.

Christiane Rüster1, Tzvetanka Bondeva, Sybille Franke, Nobushige Tanaka, Hiroshi Yamamoto, Gunter Wolf.   

Abstract

BACKGROUND: Advanced glycation end products (AGEs) play an important role in diabetic nephropathy. The receptor for AGEs, called RAGE, is present on podocytes. We investigated whether angiotensin II (ANG II) modulates RAGE expression on cultured differentiated podocytes.
RESULTS: Cultured podocytes expressed AT1 and AT2 receptors. Surprisingly, ANG II induced RAGE mRNA and protein expression through AT2 receptors. ANG II had no influence on proliferation or protein content of podocytes. The increase in RAGE expression depended on stimulated transcriptional activity. Using various mutant reporter constructs of the RAGE promoter region, it was shown that a NF-kappaB binding site at -1519 was essential for ANG II-induced transcriptional activity. Preincubation with ANG II increased the expression of tumor necrosis factor-alpha mRNA and protein expression induced by AGE, indicating that the ANG II-mediated upregulation of RAGE has functional consequences. AGE-BSA was incorporated into cells as measured by Western blots for N epsilon-carboxymethyllysine, but ANG II did not influence this process. ANG II in the absence or presence of AGE-BSA did not induce apoptosis of podocytes.
CONCLUSION: Our study revealed aninteraction between the renin-angiotensin system and the AGE/RAGE axis in podocytes. Since intraglomerular ANG II levels are increased in diabetic nephropathy, this interaction may have pathophysiological consequences for podocyte injury and inflammation associated with the development of diabetic nephropathy. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129693     DOI: 10.1159/000191467

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  12 in total

Review 1.  RAGE and the pathogenesis of chronic kidney disease.

Authors:  Vivette D'Agati; Ann Marie Schmidt
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

2.  Activation of NFAT signaling in podocytes causes glomerulosclerosis.

Authors:  Yinqiu Wang; George Jarad; Piyush Tripathi; Minggui Pan; Jeanette Cunningham; Daniel R Martin; Helen Liapis; Jeffrey H Miner; Feng Chen
Journal:  J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 10.121

3.  Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.

Authors:  K C Sourris; A L Morley; A Koitka; P Samuel; M T Coughlan; S A Penfold; M C Thomas; A Bierhaus; P P Nawroth; H Yamamoto; T J Allen; T Walther; T Hussain; M E Cooper; J M Forbes
Journal:  Diabetologia       Date:  2010-07-15       Impact factor: 10.122

Review 4.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

5.  Advanced glycated end-products affect HIF-transcriptional activity in renal cells.

Authors:  Tzvetanka Bondeva; Juliane Heinzig; Carola Ruhe; Gunter Wolf
Journal:  Mol Endocrinol       Date:  2013-09-12

6.  The directed differentiation of human iPS cells into kidney podocytes.

Authors:  Bi Song; Alexandra M Smink; Christina V Jones; Judy M Callaghan; Stephen D Firth; Claude A Bernard; Andrew L Laslett; Peter G Kerr; Sharon D Ricardo
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.

Authors:  Shiao-Ying Chang; Yun-Wen Chen; Isabelle Chenier; Stella Le Minh Tran; Shao-Ling Zhang
Journal:  Exp Diabetes Res       Date:  2011-10-27

Review 8.  Regulation of RAGE for attenuating progression of diabetic vascular complications.

Authors:  Myat Thu Thu Win; Yasuhiko Yamamoto; Seiichi Munesue; Hidehito Saito; Dong Han; So Motoyoshi; Tarek Kamal; Takuro Ohara; Takuo Watanabe; Hiroshi Yamamoto
Journal:  Exp Diabetes Res       Date:  2011-10-29

Review 9.  Role of Podocyte Injury in Glomerulosclerosis.

Authors:  Chen-Chen Lu; Gui-Hua Wang; Jian Lu; Pei-Pei Chen; Yang Zhang; Ze-Bo Hu; Kun-Ling Ma
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis.

Authors:  Rui Liu; Cai-Xia Wu; Dan Zhou; Fan Yang; Shuo Tian; Li Zhang; Tian-Tai Zhang; Guan-Hua Du
Journal:  BMC Med       Date:  2012-09-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.